Amicus Therapeutics Inc (NASDAQ: FOLD) is -16.35% lower on its value in year-to-date trading and has touched a low of $9.02 and a high of $14.57 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The FOLD stock was last observed hovering at around $12.01 in the last trading session, with the day’s loss setting it -0.14%.
Currently trading at $11.87, the stock is 10.24% and 6.16% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.54 million and changing -1.17% at the moment leaves the stock 5.91% off its SMA200. FOLD registered 8.90% gain for a year compared to 6-month gain of 10.83%. The firm has a 50-day simple moving average (SMA 50) of $11.1754 and a 200-day simple moving average (SMA200) of $11.21545.
The stock witnessed a 5.79% loss in the last 1 month and extending the period to 3 months gives it a 14.69%, and is 15.13% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.23% over the week and 3.50% over the month.
Amicus Therapeutics Inc (FOLD) has around 517 employees, a market worth around $3.52B and $455.65M in sales. Fwd P/E is 60.75. Profit margin for the company is -26.23%. Distance from 52-week low is 31.60% and -18.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-21.03%).
with sales reaching $135.37M over the same period.The EPS is expected to grow by 63.77% this year, but quarterly earnings will post 29.50% year-over-year. Quarterly sales are estimated to grow 30.80% in year-over-year returns.
Amicus Therapeutics Inc (FOLD) Top Institutional Holders
351.0 institutions hold shares in Amicus Therapeutics Inc (FOLD), with institutional investors hold 108.38% of the company’s shares. The shares outstanding are 293.59M, and float is at 289.03M with Short Float at 7.52%. Institutions hold 107.57% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 28.59 million shares valued at $283.6 million. The investor’s holdings represent 9.4382% of the FOLD Shares outstanding. As of 2024-06-30, the second largest holder is PERCEPTIVE ADVISORS LLC with 28.06 million shares valued at $$278.33 million to account for 9.2629 of the shares outstanding. The other top investors are AVORO CAPITAL ADVISORS LLC which holds 27.4 million shares representing 9.0458% and valued at over $271.81 million, while BLACKROCK INC. holds 8.046 of the shares totaling 24.37 million with a market value of $241.77 million.
Amicus Therapeutics Inc (FOLD) Insider Activity
The most recent transaction is an insider sale by Campbell Bradley L, the company’s President and CEO. SEC filings show that Campbell Bradley L sold 7,500 shares of the company’s common stock on Oct 01 ’24 at a price of $10.60 per share for a total of $79492.0. Following the sale, the insider now owns 0.89 million shares.
Still, SEC filings show that on Sep 03 ’24, Campbell Bradley L (President and CEO) disposed off 7,500 shares at an average price of $11.71 for $87798.0. The insider now directly holds 886,654 shares of Amicus Therapeutics Inc (FOLD).
